Company / Free Cash Flow
Cyclerion Therapeutics, Inc. Free Cash Flow History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$40.6M
FY2022
5-year range
-$74.0M / -$40.6M
FY2019-FY2022
Trend
+45.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$109M to -$41M over the past 2 years.
Based on SEC 10-K filings.
-$41M in FY2022.
Improved from -$109M to -$41M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, free cash flow increased 45.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -$40.6M | +45.1% |
| FY2021 | -$74.0M | +32.2% |
| FY2020 | -$109.1M | -8.1% |
| FY2019 | -$100.9M | - |
As of FY2022 · SEC 10-K Annual Filings · Updated Jun 24, 2026